LEISHMANIA SP - ANVISA Registration 10259610226

Access comprehensive regulatory information for LEISHMANIA SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10259610226 and manufactured by manufacturer not specified. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until Sep 19, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ADVAGEN BIOTECH LTDA, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10259610226
2 Related Devices
Registration Details
ANVISA Registration Number: 10259610226
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

LEISHMANIA VIRCLIA IgG+IgM MONOTEST
Risk Class III

Registration Details

10259610226

25351148693202366

68814961000173

Company Information

Dates and Status

Mar 27, 2023

19/09/2026

09/18/2025 19:00:01

LEISHMANIA VIRCLIA IgG+IgM MONOTEST
Risk Class III

Registration Details

10259610226

25351148693202366

68814961000173

Company Information

VIRCELL S.L.
Spain
PT: ESPANHA

Dates and Status

Mar 27, 2023

19/09/2026

09/18/2025 19:00:01